Boston Scientific Corp Liquidation Value
BSX
Other
Cash & Equivalents
$1.97B
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $1.97B
Total Obligations: -$17.23B
$-15.27B
Per share: $-10.91
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $1.97B
AR: $0
Total Obligations: -$17.23B
$-15.27B
Per share: $-10.91
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $1.97B
AR: $0
Inventory: $2.94B
Total Obligations: -$17.23B
$-12.33B
Per share: $-8.81
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-15.27B | $-10.91 |
| Liquid Liquidation Value | $-15.27B | $-10.91 |
| Operating Liquidation Value | $-12.33B | $-8.81 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $1.97B |
| Accounts Receivable | N/A |
| Inventory | $2.94B |
| Current Liabilities | $5.44B |
| Long-term Debt | $11.14B |
| Op. Lease Liability | $536.00M |
| Finance Lease | $123.00M |
| Shares Outstanding | N/A |
Explore all 298 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.97B | N/A | $2.94B | $1.14B | $5.44B | $11.14B | $536.00M | $123.00M |
| 2025-09-30 | $1.27B | N/A | $2.92B | $1.00B | $5.33B | $22.72B | $445.00M | $195.00M |
| 2025-06-30 | $534.00M | N/A | $2.86B | $962.00M | $5.19B | $22.69B | $440.00M | N/A |
| 2025-03-31 | $725.00M | N/A | $2.87B | $1.00B | $5.06B | $21.84B | $399.00M | N/A |
| 2024-12-31 | $414.00M | N/A | $2.81B | $960.00M | $6.40B | $19.71B | $482.00M | N/A |
| 2024-09-30 | $2.50B | N/A | $2.75B | $907.00M | $5.91B | $20.12B | $373.00M | N/A |
| 2024-06-30 | $2.91B | N/A | $2.61B | $906.00M | $5.58B | $19.56B | $365.00M | N/A |
| 2024-03-31 | $2.33B | N/A | $2.56B | $921.00M | $4.92B | $20.15B | $382.00M | N/A |
▼ Community Notes